How Epigenetics are Helping Life Insurers Keep People Alive Longer (w/Jon Sabes, CEO FOXO Technologies)

Jon R. Sabes is the founder, chief executive officer and chairman of FOXO Technologies Inc. a technology startup using the science of AI and epigenetics to reinvent the life insurance industry.

Insights in this episode:

- How longevity science is becoming core to the life insurance industry, better predicting mortality risk

- How to create and use an epigenetic clock of how people are biologically aging from your zygote double-strand starting from mom and dad's genetics through an entire lifetime  

- Why genes express the way they do, and how that can change over your lifetime affected by disease, aging, environmental and lifestyle factors 

- The industry move to 'fluidless' and how Covid brought accelerated underwriting protocols forward 5-10 years

- Giving consumers insights into their own biological aging and molecular health fingerprint, including 'indulgence exposures' to establish a baseline and make recommendations to stay healthy and extend your longevity 

Mr. Sabes is an active financial entrepreneur with over 25 years of experience, having structured over $1 billion in financing commitments for a variety of businesses.

Follow the Insurtech Leadership Podcast airing weekly hosted by Joshua R. Hollander. We give you up-close access and personal insights from the leaders of the fastest-growing #insurtechs and most innovative #insurance carriers and brokers.

For important legal information related to FOXO’s SPAC announcement, please see the following SEC disclosure at bit.ly/social-disclaimer.